Retail Investors Say Don’t Miss This Top Biotech Stock With Huge Upside Potential

We just covered the 10 Stocks That Will 10X According to Social Media. Sellas Life Sciences (NASDAQ:SLS) ranks #10 (see 5 Stocks That Will 10X According to Social Media).

Number of Hedge Fund Investors: 13

Sellas Life Sciences (NASDAQ:SLS) is one of the top favorite stocks social media believes can 10x. It is a biotech company developing a cancer immunotherapy drug called GPS — a treatment that works by training a patient’s own immune system to recognize and attack cancer cells, rather than using traditional chemotherapy. Sellas Life Sciences (NASDAQ:SLS) is currently testing GPS on acute myeloid leukemia, one of the most aggressive and deadly forms of blood cancer, in a large clinical trial called the REGAL trial.

Social media users call this one of the most compelling trial setups they have ever seen. Reddit is excited about this stock because it is not a traditional drug bet — it is a data science and modeling bet. One social media commenter holding 168,000 shares and 2,500 deep-in-the-money call options described it as “the strongest canon of due diligence I’ve ever found for a stock.”

Sellas Life Sciences’ (NASDAQ:SLS) growth catalyst is simple — a successful trial readout would almost certainly trigger a buyout from a major pharmaceutical company. Bulls believe the drug could become a standard of care for leukemia and potentially expand to other cancers, making it an extremely valuable acquisition target. Bears argue that 10x from the current price of around $8-9 is unrealistic, with most sober estimates pointing to a 3-5x return on a buyout rather than a moonshot.

Sellas Life Sciences (NASDAQ:SLS)

ESB Professional/Shutterstock.com

While we acknowledge the risk and potential of SLS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SLS and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1